Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Bronchial hyperreactivity
ADR ID BADD_A06366
ADR Hierarchy
22      Respiratory, thoracic and mediastinal disorders
22.03      Bronchial disorders (excl neoplasms)
22.03.01      Bronchospasm and obstruction
22.03.01.016      Bronchial hyperreactivity
Description Tendency of the smooth muscle of the tracheobronchial tree to contract more intensely in response to a given stimulus than it does in the response seen in normal individuals. This condition is present in virtually all symptomatic patients with asthma. The most prominent manifestation of this smooth muscle contraction is a decrease in airway caliber that can be readily measured in the pulmonary function laboratory. [MeSH]
MedDRA Code 10066091
MeSH ID D016535
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Reactive airways disease | Bronchial hyperactivity | Hyperactive airway disease | Bronchial hyperreactivity | Bronchial hypersensitivity | Bronchial Hyperreactivity | Bronchial Hyperreactivities | Hyperreactivities, Bronchial | Hyperreactivity, Bronchial
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01818Pramipexole dihydrochloride--
BADD_D01856Propafenone--
BADD_D01867Propranolol0.000160%
BADD_D01921Regadenoson--
BADD_D01937Rifapentine--
BADD_D01956Rivastigmine tartrate--
BADD_D02076Strontium ranelate--
BADD_D02170Testosterone--
BADD_D02232Tobramycin0.000149%
BADD_D02236Tofacitinib0.000241%
The 2th Page    First    Pre   2    Total 2 Pages